000 | 01898 a2200505 4500 | ||
---|---|---|---|
005 | 20250514182619.0 | ||
264 | 0 | _c20041221 | |
008 | 200412s 0 0 eng d | ||
022 | _a0969-8051 | ||
024 | 7 |
_a10.1016/j.nucmedbio.2003.10.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShi, Bingzhi | |
245 | 0 | 0 |
_aSynthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5'-(18)F-fluoropentyl)aminotetralin ((18)F-5-OH-FPPAT) in rodents and nonhuman primates. _h[electronic resource] |
260 |
_bNuclear medicine and biology _cApr 2004 |
||
300 |
_a303-11 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
650 | 0 | 4 | _aDopamine D2 Receptor Antagonists |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsotope Labeling _xmethods |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMacaca mulatta |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMetabolic Clearance Rate |
650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
650 | 0 | 4 | _aPrimates |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aRadiopharmaceuticals _xchemical synthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Dopamine D2 _xmetabolism |
650 | 0 | 4 | _aReceptors, Dopamine D3 |
650 | 0 | 4 | _aRodentia |
650 | 0 | 4 | _aSpecies Specificity |
650 | 0 | 4 |
_aTetrahydronaphthalenes _xchemistry |
650 | 0 | 4 | _aTissue Distribution |
700 | 1 | _aNarayanan, Tanjore K | |
700 | 1 | _aChristian, Bradley T | |
700 | 1 | _aChattopadhyay, Sankha | |
700 | 1 | _aMukherjee, Jogeshwar | |
773 | 0 |
_tNuclear medicine and biology _gvol. 31 _gno. 3 _gp. 303-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.nucmedbio.2003.10.004 _zAvailable from publisher's website |
999 |
_c14746247 _d14746247 |